RCM
GH icon

Raleigh Capital Management’s Guardant Health GH Stock Holding History

Raleigh Capital Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5
Closed -$260 – 598
2025
Q2 		$260 Hold
5
– – ﹤0.01% 552
2025
Q1 		$213 Sell
5
-795
-99% -$34.3K ﹤0.01% 514
2024
Q4 		$24.4K Buy
+800
New +$22.5K 0.01% 420

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Raleigh Capital Management's GH Position: Q3 2025 in Review

Raleigh Capital Management sold out of Guardant Health (GH) in Q3 2025, closing a stake of 5 shares — an estimated $260 sold.

Raleigh Capital Management first reported a position in GH in Q4 2024 and held it in 3 quarters. The position peaked at $24.4K in Q4 2024. 395 funds tracked by Wall St. Rank hold GH as of Q3 2025.

  • Raleigh Capital Management reported no remaining Guardant Health position as of Q3 2025 after selling out during the quarter.
  • Raleigh Capital Management sold 5 Guardant Health shares in Q3 2025, an estimated $260.
  • Raleigh Capital Management first reported a position in Guardant Health in Q4 2024 and held it in 3 quarters.
  • Raleigh Capital Management's Guardant Health position peaked at $24.4K in Q4 2024.
  • 395 funds tracked by Wall St. Rank held Guardant Health as of Q3 2025.

Based on Raleigh Capital Management's 13F filing for Q3 2025, filed 4 Nov 2025.